Afshin Safavi, Ph.D.

Dr. Afshin Safavi is a founder, consultant, board member, entrepreneur, and investor in the biotechnology, pharmaceutical, Animal Health, technology, and real-estate sectors. He has extensive experience establishing and leading teams in pharmaceutical and manufacturing companies and is responsible for multiple drug products in the market today.

Before founding Colorado Health and Tech Centers (CHTC) and NOVEL351K, he founded BioAgilytix Labs, one of the most successful multi-billion dollar Contract Research Organizational known internationally. Before these, he worked for various organizations, including AAIPharma, Bayer Biologicals, Talecris BioTherapeutics (Grifols), Nobex Corporation, GlaxoSmithKline, and IGEN International. Dr. Safavi obtained his B.S. in Biochemistry from UCLA, his Ph.D. in Biochemistry from the University of Kentucky Medical School, and completed a two-year postdoctoral assignment at the Emory University, Department of Pathology.